Han Jin Cho Selected Research

Edema (Dropsy)

11/2014	Berteroin present in cruciferous vegetables exerts potent anti-inflammatory properties in murine macrophages and mouse skin.
10/2013	Erucin exerts anti-inflammatory properties in murine macrophages and mouse skin: possible mediation through the inhibition of NFκB signaling.
5/2013	Mechanisms by which licochalcone e exhibits potent anti-inflammatory properties: studies with phorbol ester-treated mouse skin and lipopolysaccharide-stimulated murine macrophages.
12/2009	Benzyl isothiocyanate exhibits anti-inflammatory effects in murine macrophages and in mouse skin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Han Jin Cho Research Topics

Disease

13	Neoplasms (Cancer) 05/2017 - 08/2003
10	Colonic Neoplasms (Colon Cancer) 09/2014 - 01/2003
7	Prostatic Neoplasms (Prostate Cancer) 01/2016 - 10/2006
5	Stroke (Strokes) 07/2021 - 11/2010
4	Edema (Dropsy) 11/2014 - 12/2009
3	Neoplasm Metastasis (Metastasis) 05/2017 - 05/2012
3	Adenocarcinoma 01/2016 - 02/2011
2	Ischemic Stroke 07/2021 - 11/2010
2	Hypoxia (Hypoxemia) 05/2017 - 05/2012
2	Infections 05/2017 - 04/2005
2	Inflammation (Inflammations) 11/2014 - 01/2008
2	Carcinogenesis 02/2011 - 08/2003
2	Hypertension (High Blood Pressure) 09/2010 - 01/2009
1	Osteoporosis 12/2021
1	Atrial Fibrillation 07/2021
1	Lymphatic Metastasis 05/2017
1	Melanoma (Melanoma, Malignant) 05/2017
1	Wounds and Injuries (Trauma) 05/2017
1	Carotid Stenosis (Carotid Artery Stenosis) 01/2016
1	Breast Neoplasms (Breast Cancer) 11/2015
1	Body Weight (Weight, Body) 11/2015
1	Transient Ischemic Attack 08/2015
1	Pathologic Constriction (Stenosis) 08/2015
1	Prostatic Intraepithelial Neoplasia 04/2015
1	Carcinoma (Carcinomatosis) 04/2015
1	Obesity 01/2015
1	Human Influenza (Influenza) 01/2015
1	Thrombosis (Thrombus) 04/2014
1	Myocardial Infarction 11/2010
1	Hemorrhage 11/2010

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 11/2015 - 12/2005
6	Conjugated Linoleic AcidsIBA 02/2010 - 01/2003
4	LipidsIBA 05/2017 - 01/2015
4	CytokinesIBA 04/2015 - 05/2012
4	LipopolysaccharidesIBA 11/2014 - 01/2008
4	IGF Type 1 Receptor (IGF 1 Receptor)IBA 09/2014 - 08/2003
3	3,3',4,5'-tetrahydroxystilbeneIBA 11/2015 - 12/2008
3	kaempferolIBA 09/2014 - 09/2013
3	1,2-Dimethylhydrazine (1,2 Dimethylhydrazine)IBA 04/2006 - 01/2003
2	Warfarin (Coumadin)FDA LinkGeneric 07/2021 - 11/2010
2	DNA (Deoxyribonucleic Acid)IBA 01/2016 - 08/2003
2	benzyl isothiocyanateIBA 01/2016 - 01/2015
2	Macrophage Colony-Stimulating FactorIBA 01/2015 - 01/2015
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 09/2014 - 05/2012
2	Anticarcinogenic AgentsIBA 09/2013 - 02/2010
2	Insulin-Like Growth Factor II (Somatomedin A)IBA 01/2012 - 01/2003
2	StilbenesIBA 11/2009 - 12/2008
2	isoliquiritigenin (GU 17)IBA 09/2009 - 10/2006
1	LigandsIBA 12/2021
1	Leucine (L-Leucine)FDA Link 12/2021
1	AnticoagulantsIBA 07/2021
1	N(4)-oleylcytosine arabinosideIBA 07/2021
1	Vitamin K FDA Link 07/2021
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2017
1	oleuropeinIBA 05/2017
1	cadherin 5IBA 05/2017
1	Vascular Endothelial Growth Factor CIBA 05/2017
1	Vascular Endothelial Growth Factor DIBA 05/2017
1	Macrophage Migration-Inhibitory FactorsIBA 05/2017
1	C-Reactive ProteinIBA 05/2017
1	glucotropeolinIBA 01/2016
1	Cyclin AIBA 11/2015
1	Cyclin D1IBA 11/2015
1	Caspase 3 (Caspase-3)IBA 11/2015
1	Transcription Factors (Transcription Factor)IBA 11/2015
1	lardIBA 04/2015
1	Conditioned Culture MediaIBA 04/2015
1	Messenger RNA (mRNA)IBA 01/2015
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2015
1	Macrophage Colony-Stimulating Factor Receptor (Receptor, Macrophage Colony Stimulating Factor)IBA 01/2015
1	ChemokinesIBA 01/2015
1	Nucleic AcidsIBA 01/2015
1	Pharmaceutical PreparationsIBA 01/2015
1	berteroinIBA 11/2014
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 11/2014
1	glucoerucinIBA 10/2013
1	erucinIBA 10/2013
1	isothiocyanic acidIBA 10/2013
1	Phorbol EstersIBA 10/2013
1	3-hydroxyflavoneIBA 09/2013
1	TeaIBA 09/2013
1	JNK Mitogen-Activated Protein KinasesIBA 05/2013
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 05/2013
1	Protein Kinase CIBA 05/2013
1	licochalcone EIBA 05/2013
1	Mitogen-Activated Protein Kinase 3IBA 05/2013
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 05/2013
1	LuteolinIBA 01/2012
1	3,3'-diindolylmethane (diindolylmethane)IBA 02/2011
1	Death Domain ReceptorsIBA 02/2011
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 02/2011
1	Neoplasm Antigens (Tumor Antigens)IBA 02/2011
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 11/2010

Therapy/Procedure

3	Stents 06/2017 - 04/2014
2	Therapeutics 07/2021 - 09/2014
1	Length of Stay 05/2017
1	Carotid Endarterectomy 01/2016
1	Oral Administration 11/2015
1	Nanospheres 01/2015
1	Thrombectomy 04/2014